Usefulness of the blood hematocrit level to predict development of heart failure in a community.
暂无分享,去创建一个
Ramachandran S Vasan | R. Vasan | Thomas J. Wang | L. Moore | M. M. Qureshi | Thomas J Wang | Muhammad M Qureshi | Lynn L Moore | Erin E Coglianese | E. Coglianese
[1] H. Schunkert,et al. Haematocrit profoundly affects left ventricular diastolic filling as assessed by Doppler echocardiography , 2000, Journal of hypertension.
[2] M. Woodward,et al. Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland , 2003, British journal of haematology.
[3] W. Kannel,et al. The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.
[4] H. Hense,et al. Haematocrit levels and left ventricular geometry: results of the MONICA Augsburg Echocardiographic Substudy , 2007, Journal of hypertension.
[5] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[6] P. Whelton,et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. , 2001, Archives of internal medicine.
[7] W. Kannel,et al. Some health benefits of physical activity. The Framingham Study. , 1979, Archives of internal medicine.
[8] G. Parati,et al. Hemodilution reduces clinic and ambulatory blood pressure in polycythemic patients. , 1998, Hypertension.
[9] T. Dawber,et al. Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.
[10] S. Neubauer,et al. Haemoglobin and flow-mediated vasodilation. , 2006, Clinical science.
[11] M. Gassmann,et al. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. , 2001, Blood.
[12] P. Sorlie,et al. Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program , 1981 .
[13] E. Ferrannini,et al. Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. , 2005, European heart journal.
[14] N. Vaziri,et al. Mechanism of erythropoietin-induced hypertension. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] W. Kannel,et al. Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up. , 1994, American heart journal.
[16] I. Anand,et al. Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia. , 1995, Journal of the American College of Cardiology.
[17] N. Vaziri. Cardiovascular effects of erythropoietin and anemia correction , 2001, Current opinion in nephrology and hypertension.
[18] Daniel L. McGee,et al. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. , 1983, American heart journal.